Treating Liver Metastases Webinar Available Online

On Monday, May 16th, 2011, Dr. Andrew Kennedy, a well-known researcher in liver metastases, led a Fight Colorectal Cancer webinar discussing an issue that affects thousands of colorectal cancer patients. Colorectal cancer often metastasizes first to the liver, so learning how to manage growth of those tumors can help with patient survival.   Treatment of liver…  Read More

Upcoming Patient Webinars Will Bring the Science to YOU

Fight Colorectal Cancer is giving you the opportunity to talk to researchers and medical professionals in April and May through online webinars designed to bring the science of treating colorectal cancer down to the personal. The latest news from the petri dish Wednesday, April 20, 2011 8 – 9 PM Eastern Dr. Rona Yaeger will discuss…  Read More

KRAS Mutations Match in Almost All Tumors

If there is a KRAS mutation in the primary colon or rectal tumor, there is almost always a matching mutation when that tumor spreads to the liver. Researchers in the Netherlands tested both tumors for KRAS mutations in over 300 patients whose cancer had spread to their livers. They found about a third of patients had…  Read More

Clinical Trial at NIH for Unresectable Liver Tumors

Patients with liver tumors, including those that have spread from colorectal cancer, can enroll in a clinical trial at the National Institutes of Health Clinical Center in Bethesda. The trial will test the effectiveness of infusing the drug melphalan through the artery that feeds the liver. Colorectal cancer patients with liver metastases are eligible for the…  Read More

Young Patients Do Worse After Surgery for Liver Mets

Patients under 40 appear to have more aggressive liver tumors from colorectal cancer and poorer long-term outcomes. After surgery to remove the cancer that had spread to their liver, patients who were 40 or younger had poorer overall survival and shorter time until cancer returned. The percentage of younger patients who were alive without cancer five…  Read More

C3 Advocates Contribute to RFA Effectiveness Review

How useful is radiofrequency ablation (RFA) in treating liver metastases from colorectal cancer? To answer that question, American Society for Clinical Oncology scientists included two C3 advocates, Rob Michelson and Dr. Andrew Guisti, on an expert panel looking at published RFA research. In appreciation, the panel dedicated their Clinical Evidence Review to Michelson who died in…  Read More